Materials • Major Chemicals
$3.65 ▲ +0.00
(0.00%)
MKT CAP: $283.1M • VOL: 625.9K
52W L $1 52W H $6
ALTO // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $917.9M | $965.3M | $1.22B |
| YoY Revenue Growth % | -4.9% | -21.1% | — |
| Gross Profit | $34.9M | $9.7M | — |
| Gross Margin % | 3.8% | 1.0% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $7.4M | -$51.7M | -$23.8M |
| Operating Margin % | 0.8% | -5.4% | -2.0% |
| Net Income (GAAP) | $13.3K | -$59.0K | -$29.3M |
| EBITDA (Normalized) | $11.0M | -$42.8M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $13.2M | -$3.5M | $22.0M |
| Capital Expenditures (CapEx) | $4.6M | $11.1M | — |
| Free Cash Flow (FCF) | $8.6M | -$14.6M | $22.0M |
| FCF Margin % | 0.9% | -1.5% | 1.8% |
| Return on Invested Capital (ROIC %) | 2.0% | -14.5% | — |
| Cash & Short-Term Equivalents | $23.4M | $35.5M | — |
| Total Debt (Short + Long Term) | $63.0M | $92.9M | — |
| Total Stockholders' Equity | $245.2M | $225.1M | — |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR ALTO.